Cyprus Pharmaceutical and Medical Goods Expenditure Share
Cyprus Pharmaceutical and Medical Goods Expenditure Share published by Eurostat, covering Cyprus at annual frequency (2005–2023).
Cyprus (2023)
17.6
% of current health expenditure
-1.0pp YoY
YoY Change
-1.0pp
percentage points
Trend
down
Series length
14
years of data
Data
| Year | % of current health expenditure | YoY Change |
|---|---|---|
| 2023 | 17.6 | -1.0pp |
| 2022 | 18.7 | +0.3pp |
| 2021 | 18.3 | +2.1pp |
| 2020 | 16.3 | -0.5pp |
| 2019 | 16.8 | -2.6pp |
| 2018 | 19.4 | -0.1pp |
| 2017 | 19.4 | -0.4pp |
| 2016 | 19.8 | +0.3pp |
| 2015 | 19.6 | +0.7pp |
| 2014 | 18.9 | +0.5pp |
| 2013 | 18.4 | +0.4pp |
| 2012 | 18.1 | +0.2pp |
| 2011 | 17.9 | -0.2pp |
| 2010 | 18.1 | n/a |
About this Dataset
Cyprus recorded 17.6 % of current health expenditure in 2023. The most recent year-on-year change was -1.0pp. The historical series (2005–2023) shows a peak of 19.8 in 2016 and a trough of 16.3 in 2020.
Data sourced from Eurostat via SDMX REST API. Values use harmonised methodology ensuring cross-country comparability within the European statistical framework.
The chart above shows the full historical trend; the table below lists annual values with year-on-year changes.
Frequently Asked Questions
This indicator tracks cyprus pharmaceutical and medical goods expenditure share in Cyprus, published by Eurostat. Data covers 2005–2023 at annual frequency using harmonised methodology.
The most recent observation covers 2023. Eurostat typically publishes this series with a lag of several months after the reference period. Data is updated annual.
The series peaked at 19.8 % of current health expenditure in 2016 and reached its lowest recorded value of 16.3 in 2020. The latest reading of 17.6 in 2023 represents a year-on-year change of -1.0pp.